Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CAH12 | O43570 | Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3) | Disease related genesEnzymesFDA approved drug targets | 1 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.25 | |||
| CANT1 | Q8WVQ1 | Soluble calcium-activated nucleotidase 1 (SCAN-1) (EC 3.6.1.6) (Apyrase homolog) (Putative MAPK-activating protein PM09) (Putative NF-kappa-B-activating protein 107) | Cancer-related genesDisease related genesEnzymes | 1 | Immune mediationReceptor-signaling mediation | 1 | 0.25 | |||
| CCR7 | P32248 | C-C chemokine receptor type 7 (C-C CKR-7) (CC-CKR-7) (CCR-7) (BLR2) (CDw197) (Epstein-Barr virus-induced G-protein coupled receptor 1) (EBI1) (EBV-induced G-protein coupled receptor 1) (MIP-3 beta receptor) (CD antigen CD197) | Cancer-related genesCD markersG-protein coupled receptors | 7 | Malignant haematopoietic neoplasmMature B-cell leukaemia | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| CD151 | P48509 | CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3) (PETA-3) (Tetraspanin-24) (Tspan-24) (CD antigen CD151) | Blood group antigen proteinsCD markersDisease related genes | 4 | Adhesion and uptake mediationImmune mediationReceptor-signaling mediation | 1 | 0.25 | |||
| CD166 | Q13740 | CD166 antigen (Activated leukocyte cell adhesion molecule) (CD antigen CD166) | Cancer-related genesCD markersPlasma proteins | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| CD80 | P33681 | T-lymphocyte activation antigen CD80 (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1) (B7) (CD antigen CD80) | CD markersFDA approved drug targetsPredicted intracellular proteins | 1 | Diabetes mellitusLung cancerLymphoma | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| CDON | Q4KMG0 | Cell adhesion molecule-related/down-regulated by oncogenes | Disease related genesHuman disease related genesPredicted membrane proteins | 1 | Receptor-signaling mediation | 1 | 0.25 | |||
| CLCN2 | P51788 | Chloride channel protein 2 (ClC-2) | Disease related genesFDA approved drug targetsHuman disease related genes | 10 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| CLTR1 | Q9Y271 | Cysteinyl leukotriene receptor 1 (CysLTR1) (Cysteinyl leukotriene D4 receptor) (LTD4 receptor) (G-protein coupled receptor HG55) (HMTMF81) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Allergic/hypersensitivity disorderAsthmaMigraine | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.25 | ||
| DNER | Q8NFT8 | Delta and Notch-like epidermal growth factor-related receptor | Cancer-related genesPredicted membrane proteins | 1 | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.25 | |||
| EAA1 | P43003 | Excitatory amino acid transporter 1 (Sodium-dependent glutamate/aspartate transporter 1) (GLAST-1) (Solute carrier family 1 member 3) | Cancer-related genesDisease related genesHuman disease related genes | 8 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.25 | |||
| ECE1 | P42892 | Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) | Disease related genesEnzymesHuman disease related genes | 1 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.25 | |||
| EFNB2 | P52799 | Ephrin-B2 (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L) | Cancer-related genesPlasma proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| FCG2B | P31994 | Low affinity immunoglobulin gamma Fc region receptor II-b (IgG Fc receptor II-b) (CDw32) (Fc-gamma RII-b) (Fc-gamma-RIIb) (FcRII-b) (CD antigen CD32) | Cancer-related genesCD markersDisease related genes | 1 | Autoimmune diseaseB-cell lymphomaDiabetes mellitus | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| FCG3A | P08637 | Low affinity immunoglobulin gamma Fc region receptor III-A (IgG Fc receptor III-A) (CD16-II) (CD16a antigen) (Fc-gamma RIII-alpha) (Fc-gamma RIII) (Fc-gamma RIIIa) (FcRIII) (FcRIIIa) (FcgammaRIIIA) (FcR-10) (IgG Fc receptor III-2) (CD antigen CD16a) | CD markersDisease related genesFDA approved drug targets | 1 | Hodgkin lymphomaLymphomaMature T-cell lymphoma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||
| FCGRN | P55899 | IgG receptor FcRn large subunit p51 (FcRn) (IgG Fc fragment receptor transporter alpha chain) (Neonatal Fc receptor) | FDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins | 1 | Acquired haemolytic anaemiaIdiopathic inflammatory myopathyInflammatory polyneuropathy | Clinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| FGFR1 | P11362 | Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331) | Cancer-related genesCD markersDisease related genes | 1 | Acute diabete complicationAcute myeloid leukaemiaAlzheimer disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||
| FGFR2 | P21802 | Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332) | Cancer-related genesCD markersDisease related genes | 1 | Alzheimer diseaseBladder cancerBreast cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||
| FREM2 | Q5SZK8 | FRAS1-related extracellular matrix protein 2 (ECM3 homolog) | Disease related genesHuman disease related genesPredicted membrane proteins | 1 | Other mediation | 1 | 0.25 | |||
| GFRA1 | P56159 | GDNF family receptor alpha-1 (GDNF receptor alpha-1) (GDNFR-alpha-1) (GFR-alpha-1) (RET ligand 1) (TGF-beta-related neurotrophic factor receptor 1) | Disease related genesPredicted intracellular proteinsPredicted membrane proteins | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.25 | ||||
| GRIA2 | P42262 | Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) | Disease related genesHuman disease related genesPotential drug targets | 3 | NeuropathyParkinsonism | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.25 | ||
| HECAM | Q14CZ8 | Hepatic and glial cell adhesion molecule (glialCAM) (Hepatocyte cell adhesion molecule) (Protein hepaCAM) | Disease related genesHuman disease related genesPotential drug targets | 1 | Adhesion and uptake mediation | 1 | 0.25 | |||
| IL1R2 | P27930 | Interleukin-1 receptor type 2 (IL-1R-2) (IL-1RT-2) (IL-1RT2) (CD121 antigen-like family member B) (CDw121b) (IL-1 type II receptor) (Interleukin-1 receptor beta) (IL-1R-beta) (Interleukin-1 receptor type II) (CD antigen CD121b) [Cleaved into: Interleukin-1 receptor type 2, membrane form (mIL-1R2) (mIL-1RII); Interleukin-1 receptor type 2, soluble form (sIL-1R2) (sIL-1RII)] | Cancer-related genesCD markersPlasma proteins | 1 | Immune system diseaseRheumatoid arthritis | Clinical-translation mediationImmune mediationMetabolism mediation | 1 | 0.25 | ||
| IL2RB | P14784 | Interleukin-2 receptor subunit beta (IL-2 receptor subunit beta) (IL-2R subunit beta) (IL-2RB) (High affinity IL-2 receptor subunit beta) (Interleukin-15 receptor subunit beta) (p70-75) (p75) (CD antigen CD122) | Cancer-related genesCD markersDisease related genes | 1 | Bladder cancerBrain cancerColorectal cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||
| IL3RA | P26951 | Interleukin-3 receptor subunit alpha (IL-3 receptor subunit alpha) (IL-3R subunit alpha) (IL-3R-alpha) (IL-3RA) (CD antigen CD123) | CD markersFDA approved drug targetsPredicted intracellular proteins | 1 | Acute myeloid leukaemiaAsthmaB-cell lymphoma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 |